Showing results (61-70 of 155) with videos related to

Sort By:
Pageof 16
Medrxiv : the Preprint Server for Health Sciences|April 10, 2026
Mutation-specific impairment of TET2 and DNMT3A enzymatic activity predicts clonal hematopoiesis disease riskYash Pershad, Kun Zhao, Joseph C Van Amburg, et al.
The Lancet. Haematology|March 31, 2019
An oral fixed-dose combination of decitabine and cedazuridine in myelodysplastic syndromes: a multicentre, open-label, dose-escalation, phase 1 studyMichael R Savona, Olatoyosi Odenike, Philip C Amrein, et al.
Haematologica|April 15, 2021
Pevonedistat and azacitidine upregulate NOXA (PMAIP1) to increase sensitivity to venetoclax in preclinical models of acute myeloid leukemiaDan Cojocari, Brianna N Smith, Julie J Purkal, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 18, 2020
Treatment Patterns and Blood Counts in Patients With Polycythemia Vera Treated With Hydroxyurea in the United States: An Analysis From the REVEAL StudyMichael R Grunwald, David J Kuter, Ivy Altomare, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 8, 2023
Phase 1/2 Study of the Pan-PIM Kinase Inhibitor INCB053914 Alone or in Combination With Standard-of-Care Agents in Patients With Advanced Hematologic MalignanciesManish R Patel, William Donnellan, Michael Byrne, et al.
The Journal of Molecular Diagnostics : JMD|July 30, 2023
Genomic Data Heterogeneity across Molecular Diagnostic Laboratories: A Real-World Connect Myeloid Disease Registry Perspective on Variabilities in Genomic Assay Methodology and ReportingJay L Patel, Harry P Erba, Michael R Savona, et al.
Nature Chemical Biology|December 3, 2021
Apoptolidin family glycomacrolides target leukemia through inhibition of ATP synthaseBenjamin J Reisman, Hui Guo, Haley E Ramsey, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 31, 2026
Spirocyclic β-lactone secondary metabolites modulate spliceosome functionKathryn E Penton, Sydney A Bates, Hannah L Thirman, et al.
Experimental Hematology|September 19, 2025
A 30-gene classifier distinguishes low-risk MDS HSPCs from healthy HSPCsPawan Bhat, Joseph C Van Amburg, Chad R Potts, et al.
Experimental Hematology|February 22, 2021
The delta isoform of phosphatidylinositol-3-kinase predominates in chronic myelomonocytic leukemia and can be targeted effectively with umbralisib and ruxolitinibMatthew T Villaume, M Pia Arrate, Haley E Ramsey, et al.
Pageof 16